Quantgene is a team of pioneers dedicated to the mission of defeating cancer. We are clinicians, technologists, data scientists and business innovators coming together to change the future of medicine.
We are Quantgene
Quantgene is a team of pioneers dedicated to the mission of defeating cancer. We are oncologists, clinicians, technologists, data scientists and business innovators coming together to change the future of medicine.
Robert is responsible for Quantgene's software infrastructure and architecture to integrate clinical, laboratory and machine learning.
Robert brings 17 years experience from the e-commerce sector, having worked with large global brands such as Columbia Sportswear, Tory Burch, Alexander Wang, S.Oliver and many more to connect their complex system landscapes into one coherent and efficiently working whole. Most recently, he worked at Mobizcorp Europe, a leading Salesforce Commerce Cloud partner, as Director of Engineering. Robert led a technical evolution to establish 24/7 Support, Security and Performance Audit services. He also helped to lead the development of mentorship and training programs within the company.
Robert has an M.Sc. in Software Engineering from Freie University of Berlin.
Pablo Gómez PhD
/ Machine Learning Research
Dr. Gómez performs R&D on Quantgene's pattern recognition challenges. His has extensive expertise in machine learning, statistics and software development.
Prior to his work at Quantgene Dr. Gómez was a Researcher at the University Hospital Erlangen where he conceived, developed and implemented several deep learning approaches for processing high-speed for the diagnosis and treatment of voice disorders. Additionally he initiated and coordinated an international collaboration to create the largest high-speed videoendoscopy dataset publicly available.
Dr. Gómez received his PhD from the Friedrich-Alexander-University Erlangen-Nuremberg. He holds a M.Sc. and B.Sc. in computer science from the Technical University Munich.
/ Neural Nets and AI
Stefan is working on Quantgene’s machine learning solution for early cancer detection. As a trained bioinformatician he has extensive and long-standing knowledge of genomics data analysis.
Prior to joining Quantgene, Stefan was a researcher at the Max Planck Institute for Molecular Genetics in Berlin where he developed machine learning models for the detection of protein-RNA interactions and for the prediction of cancer-related genes. Most notably, his work focused on the interpretability of deep learning approaches to uncover and to explain why a certain prediction has been made. Stefan holds a B.Sc. and M.Sc. in Bioinformatics from the Free University of Berlin.
/ Data Science
Larry is a Data Scientist at Quantgene and is responsible for collecting, cleaning, and analyzing data. With a background in Data Science, he processes data which is fed into predictive models and machine learning algorithms.
Prior to joining Quantgene, Larry attended the University of California, Berkeley, where he received a B.A. in Computer Science and a B.A. in Economics.
/ Software Engineer
Bogdan is responsible for writing the software required in Quantgene's products, be it complex Viewing and Editing interfaces, websites, User Experience analysis or building subtle, efficient, ways of consuming the ever-growing amount of data.
He brings a combined experience of over 12 years of software engineering, e-commerce development, user experience know-how and gamification strategy.Driven by the Idea and then the tools, he created and implemented a unique game world, built e-commerce businesses while also developing problem-solving software solutions that still help hundreds of businesses all around the world.
Bogdan has B.Sc. in Computer Science from A.I. Cuza University, Iasi
Sebastian Pfeil PhD
Sebastian provides biointelligence to Quantgene's DEEPSEQ pipeline and is responsible for the development and implementation of effective alignment, variant calling and noise cancelation strategies. As part of Quantgene's pattern recognition unit, he is working on expanding the portfolio to include other tumor entities and diseases.
He brings combined experience of over 11 years from the fields of genomics, data analysis and oncology. Before joining Quantgene, he worked in the research department of pedeatric oncology at Charite Berlin on a translational project to identify molecular targets using NGS data sets in neuroblastoma. During his PhD, Sebastian worked at the Leibniz Institute for Molecular Pharmacology on the development of paharmacologically active substances to transiently modulate the blood-brain barrier.
Sebastian has a PhD in biochemistry from the Free University of Berlin.
Bernd Timo Hermann PhD
/ Quantitative Genomics
Bernd is responsible for the data driven evaluation and optimization of Quantgene' DEEPSEQ pipeline, including the utilized panel of primer and genomic targets. He is also part of the pattern recognition unit and identifies new patterns in patient data using statistical analysis.
Before joining Quantgene, Bernd completed his doctoral thesis at the Helmholtz Centre for Ocean Research (GEOMAR) where he investigated the impact of chronic stress on fish species – a interdisciplinary field of research, combing different themes such as animal welfare, climate change, physiology and biomarker evaluation. With additional experience in the biotech industry, he gained a strong background in molecular biology, particularly in the handling and analysis of omics data. This expertise was fostered by the completion of advanced trainings in bioinformatics and data analysis.
Bernd has a PhD in biology from the Christian-Albrechts-University (CAU) in Kiel, Germany
Nivi is responsible for developing and expanding Quantgene’s mutation panels for early cancer detection. She also performs R&D for new projects/products.
Prior to joining Quantgene, Nivi has worked in other roles within the biological field. She has experience with in vivo research, using mice as a model to study the role of extracellular matrix in fighting respiratory infections. She also has experience in computational biology, developing a novel Python-based system to better visualize MD simulations of proteins.
Nivi has a B.S. in Molecular Biology (Cellular and Developmental) and minor in Computer Science from the University of Pittsburgh.
William Ricketts, PhD
/ Director of Clinical Affairs
William Ricketts, PhD is the Director of Clinical Affairs at Quantgene and is responsible for developing studies to validate new products and identifying areas of unmet medical need.
Dr. Ricketts has been in diagnostic development for more than fifteen years. He has designed, developed, and launched several CLIA cleared tests for cancer and autoimmune disease. In this role, he has written protocols and worked extensively with physicians to validate new tests and technologies for use in the clinical laboratory.
Dr. Ricketts received his BA from the University of Virginia and his PhD from the University of CA-San Diego. He is currently a Society of Gynecologic Oncology member and the American Association of Cancer Researchers.
Petra Gambon Stow
/ Clinical Research Coordination
Petra is responsible for the data management and the sample collection for Quantgene's feasibility study at the University Hospital Geneva. She also works closely with executive management to strategize and execute clinical trials.
Her qualifications include: - Certificate of Advanced Studies, Study Coordinator, Clinical Research 1, Bâle, Switzerland - Qualified Training Practitioner (Certificate of Advanced Studies) 2010, - Study coordinator at the visceral surgical department, obesity surgery at the Hospital University of Geneva, Switzerland
/ Senior Director, Marketing
Jennifer is responsible for Quantgene’s marketing strategy, planning and implementation across corporate, employer and product brands. She manages the marketing team and is working to build out the department structure as the company continues to grow.
Jennifer brings with her 14 years of healthcare marketing and advertising experience. She has deep expertise in strategic patient-centric marketing having worked with world-leading companies including Gilead, J&J, Merck, Sanofi and Lilly. She has also led the launch of several pharmaceutical brands including Cialis for BPH, Sanofi’s insulin Toujeo and the omni-channel support platform for Gilead’s Hepatitis C portfolio. Most recently, Jennifer held the role of Group Account Director at Wunderman Health overseeing multiple pieces of business with a focus on data-driven marketing.
Jennifer spent 9 years growing up in Tokyo Japan; an experience that has added to her understanding of diversity and nuance in her work. Jennifer has a B.A. in Psychology from Columbia University’s Barnard College.
/ Director of Growth Marketing
Tim drives Quantgene’s acquisition strategy and is responsible for developing multi-channel campaigns, including paid search, display, social, and content-based inbound marketing. He develops and deploys lead nurturing strategies, retention campaigns, and customer experience touch-points central to loyalty and engagement.
Tim has over 15 years’ experience driving growth in tech-based industries. Before joining Quantgene, Tim served as a consultant and fractional CMO to entrepreneurial ventures with an emphasis on leading marketing teams through transitions involving rapid growth.
He has his MBA, Marketing from the Bloch School at the University of Missouri, and a BA in Philosophy from Conception College.
/ Strategic Partnerships
Anders is in charge of strategic partnerships at Quantgene with a focus on both commercial and clinical channels. Anders takes a multifactorial approach to building Quantgene's industry rapport while focusing on growth. His software and community building experience as the founder of a handful of technology startups adds an entrepreneurial approach to business development.
Anders studied economics at Boston College and the London School of Economics and enjoys surfing and cooking in his free time.